Sound Biologics is a clinical-stage biotechnology company with proprietary technologies and platforms for creating next-generation therapeutic antibodies designed to target multiple molecules and pathways. We have built a broad and diverse pipeline spanning oncology, autoimmune, and neurodegenerative diseases. We are actively seeking strategic partners across programs at various stages of development and are open to a range of collaboration structures, including out-licensing, co-development, and NewCo creation.